Company / Cost of Revenue
Tanke Biosciences Corp Cost of Revenue History
FY2011-FY2012 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$18.6M
FY2012
5-year range
$15.1M / $18.6M
FY2011-FY2012
Trend
+23.6%
vs FY2011
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$19M in FY2012.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2012, cost of revenue increased 23.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2012 | $18.6M | +23.6% |
| FY2011 | $15.1M | - |
As of FY2012 · SEC 10-K · Updated Jun 29, 2026